Critical Limb Ischemia: Wound Blush Is the Most Important Objective

Critical Limb Ischemia: Wound Blush The aim of this study was to find the optimal angiographic endpoint for infrapopliteal interventions to be able to predict wound healing.

 

Evidence shows acceptable patency and successful limb salvage in patients with critical limb ischemia after infrapopliteal intervention. However, the optimal angiographic endpoint remains unclear. Is it enough to restore flow in one vessel or is it necessary to treat them all? And we should also consider the angiosome guided revascularization approach.

 

Several studies have been conducted to try answer the question of optimal infrapopliteal angioplasty enpoint in patients with critical limb ischemia. This is a subanalysis of the prospective multicenter registry OLIVE (Endovascular Treatment for Infrainguinal Vessels in Patients with Critical Limb Ischemia), that included patients with critical limb ischemia and infrainguinal disease.

 

Researchers analyzed 185 limbs with ischemic ulcers classified as Rutherford 5 or 6 undergoing endovascular treatment.

 

The association of final angiographic outcome and ulcer healing was done using the Cox model.

 

Wound healing rate was 73.5%. The probabilities of proper wound healing were significantly higher in patients with wound blush (79.6% vs. 46.5%; p = 0.01). Wound blush was an independent predictor of wound healing.

 

Conclusion

The presence of wound blush after infrapopliteal intervention was associated with wound healing. Wound blush could be a new angiographic predictor of success in patients with critical limb ischemia

 

Editorial Comment

This new concept complements the angiosome guided approach. In fact, successful angiosome revascularization and ulcer flow restoration may most likely produce wound blush. The benefit of this new concept is that it is far easier to assess in the cath lab and a lot easier to remember (compared to the angiosome), since it reminds us of the myocardial blush of primary PCI.

 

Original Title: Wound Blush Obtainment Is the Most Important Angiographic Endpoint for Wound Healing.

Reference: Makoto Utsunomiya et al. JACC Cardiovasc Interv. 2017 Jan 23;10(2):188-194.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...